ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

31,152Medicare Part D Prescriptions Filled, Including Refills

Rank: 12 out of 1000

$1.11M Total Retail Price of All Prescriptions

Rank: 35 out of 1000

1,033 Patients Receiving at Least One Drug in Part D
70%Patients 65 Years and Older
53% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

1% of this provider’s 1,033 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

36% of this provider’s 1,033 patients filled at least one prescription for a schedule three drug, compared to an average of 20%.

Risky Drugs to Seniors

4% of this provider’s 21,199 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

14% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$36 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
HYDROCODONE-ACETAMINOPHEN 2,583 1,543 S3 1 1
PRAVASTATIN SODIUM 1,466 1,010 2 12
LISINOPRIL 1,034 727 3 5
METFORMIN HCL 996 662 4 8
OMEPRAZOLE 933 637 5 2
AMLODIPINE BESYLATE 784 593 6 6
LEVOTHYROXINE SODIUM 765 627 7 4
HYDROCHLOROTHIAZIDE 750 610 8 9
ENALAPRIL MALEATE 730 545 9 58
FUROSEMIDE 604 442 10 7
GABAPENTIN 566 396 11 11
SIMVASTATIN 547 394 12 3
METOPROLOL SUCCINATE 506 341 13 21
ATENOLOL 493 365 14 24
CITALOPRAM HBR 484 319 15 17
PANTOPRAZOLE SODIUM 471 293 16 28
CARVEDILOL 470 352 17 15
METOPROLOL TARTRATE 424 307 18 19
FENOFIBRATE 384 277 19 55
SERTRALINE HCL 355 229 20 26
MELOXICAM 351 235 21 14
LOSARTAN POTASSIUM 345 308 22 25
TRAMADOL HCL 343 217 23 13
GEMFIBROZIL 341 251 24 105
TAMSULOSIN HCL 296 217 25 33
LOVASTATIN 284 212 26 41
GLIMEPIRIDE 283 180 27 34
CLONIDINE HCL 283 217 27 27
LISINOPRIL-HYDROCHLOROTHIAZIDE 274 171 29 20
ZOLPIDEM TARTRATE 256 127 30 16
QUINAPRIL HCL 256 209 30 117
RANITIDINE HCL 251 159 32 37
TIZANIDINE HCL 234 68 33 76
NEXIUM 216 115 34 23
CYCLOBENZAPRINE HCL 215 98 R 35 39
ATORVASTATIN CALCIUM 201 148 36 18
TERAZOSIN HCL 196 152 37 150
AMITRIPTYLINE HCL 194 129 R 38 45
DOXAZOSIN MESYLATE 187 164 39 111
CLOPIDOGREL 186 134 40 35
TRAZODONE HCL 186 125 40 29
HYDRALAZINE HCL 180 141 42 74
PROAIR HFA 167 81 43 50
BUPROPION HCL SR 166 59 44 183
ADVAIR DISKUS 163 105 45 65
PROMETHAZINE HCL 163 56 R 45 54
ALLOPURINOL 162 110 47 31
DONEPEZIL HCL 157 142 48 32
LYRICA 152 98 49 47
FLUTICASONE PROPIONATE 146 73 50 40
SPIRONOLACTONE 141 105 51 78
BACLOFEN 140 72 52 129
ESCITALOPRAM OXALATE 138 72 53 60
GLIPIZIDE 133 102 54 62
VENTOLIN HFA 131 84 55 83
INSULIN SYRINGE 130 80 56 93
FLUOXETINE HCL 126 18 57 51
KLOR-CON M20 123 92 58 66
ESTRADIOL 120 86 R 59 114
POLYETHYLENE GLYCOL 3350 115 80 60 69
GUANFACINE HCL 112 97 R 61 295
IBUPROFEN 112 51 61 94
ISOSORBIDE MONONITRATE ER 111 79 63 71
WARFARIN SODIUM 110 72 64 22
AZITHROMYCIN 106 73 65 36
PLAVIX 101 75 66 49
HUMULIN 70-30 100 57 67 131
NIASPAN 100 88 67 172
LANTUS SOLOSTAR 98 54 69 120
ROPINIROLE HCL 94 47 70 82
DIOVAN HCT 92 75 71 96
ACETAMINOPHEN-CODEINE 91 67 S3 72 127
SINGULAIR 90 42 73 84
DICLOFENAC SODIUM 90 50 73 123
FINASTERIDE 88 88 75 177
GLYBURIDE 87 87 R 76 92
SPIRIVA 85 67 77 64
LOSARTAN-HYDROCHLOROTHIAZIDE 84 59 78 38
VERAPAMIL ER 83 64 79 86
DIOVAN 81 70 80 67
POTASSIUM CHLORIDE 78 57 81 10
PREDNISONE 77 53 82 42
LACTULOSE 76 66 83 162
COLCRYS 76 57 83 171
QUETIAPINE FUMARATE 74 44 85 75
GLYBURIDE-METFORMIN HCL 73 73 R 86 121
CRESTOR 71 48 87 30
METHOCARBAMOL 70 35 R 88 79
FOSINOPRIL SODIUM 69 55 89 154
CYMBALTA 69 0 89 53
BUSPIRONE HCL 68 26 91 110
NAPROXEN 68 37 91 81
TRIAMTERENE-HCTZ 66 54 93 48
PAROXETINE HCL 65 47 94 63
BISOPROLOL-HYDROCHLOROTHIAZIDE 65 43 94 101
DILTIAZEM ER 64 56 96 146
SYNTHROID 63 54 97 91
SYMBICORT 62 45 98 149
OXYBUTYNIN CHLORIDE ER 61 40 99 157
MONTELUKAST SODIUM 61 31 99 132
AMOXICILLIN 60 39 101 89
MECLIZINE HCL 60 40 101 80
PREMARIN 59 38 R 103 109
FAMOTIDINE 58 46 104 88
CLOTRIMAZOLE-BETAMETHASONE 58 40 104 173
SULFAMETHOXAZOLE-TRIMETHOPRIM 58 34 104 70
DILTIAZEM 24HR ER 54 51 107 189
NAMENDA 53 51 108 43
JANTOVEN 51 51 109 292
CELEBREX 50 36 110 98
LANTUS 50 21 110 68
DIGOXIN 50 33 110 52
KLOR-CON 10 50 49 110 104
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 7, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.